Latest news
Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $43 - MoomooMoomoo · Fri, 07 Aug 2026 20:49:13 GMTImmunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues - TradingViewTradingView · Fri, 07 Aug 2026 17:27:00 GMTImmunocore Holdings PLC (IMCR) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 15:13:27 GMTWall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - Zacks Investment ResearchZacks Investment Research · Fri, 07 Aug 2026 13:02:14 GMTHow Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 08:15:20 GMTIMCR SWOT Analysis: Growth Potential Amidst Financial Challenges Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 07 Aug 2026 06:48:48 GMTImmunocore Holdings plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 05:13:27 GMTImmunocore reports second quarter financial results and provides a business update - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 04:14:05 GMT